Within the past year there has been considerable publicity about a new outbreak of lymphogranuloma venereum (LGV). LGV is a serious sexually transmitted disease caused by a particularly aggressive strain of Chlamydia trachomatis that is considered a distinct biovar. This disease is generally considered to be one that is usually seen in tropical countries. But in 2003, it was detected in the Netherlands, followed by sporadic reports of cases from other countries in Western Europe and North America. A major concern has been that this disease can enhance HIV transmission. Public health authorities have expressed concerns about the possible spread of this disease into the United States.
Julius Schachter, PhD, in his editorial in the June 2005 issue of Sexually Transmitted Diseases, points out that this disease has actually been present in the United States for many decades and suggests that it is endemic in this country. In the U.S., the major clinical manifestation is proctitis in men who have sex with men, rather than the typical presentation of genital ulcers and bubos that is characteristic in developing countries. Schachter suggests the recent detection of cases in the U.S. actually reflects the use of sophisticated diagnostic tests capable of differentiating the LGV infection from the more common chlamydial infections that are highly prevalent. In other words, this is not a newly introduced disease or a new epidemic, but simply an application of new technology that is identifying infections which have not been previously recognized yet have been present in the United States all along.
Schachter is professor of laboratory medicine in the Department of Laboratory Medicine for the University of California San Francisco. Schachter is also past-president of the American Sexually Transmitted Disease Association and chair of the Sexually Transmitted Diseases Diagnostics Initiative of the World Health Organization. His current research focuses on the epidemiology and clinical manifestations of chlamydial infections, as well as the evaluation of newly developed diagnostic methods for chlamydial infections.
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.